Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  De Souza, Fernanda Mattos ^a   Do Prado, Thiago Nascimento ^a   Pinheiro, Jair Dos Santos ^c   Peres, Renata Lyrio ^a   Lacerda, Thamy Carvalho ^a   Loureiro, Rafaela Borge ^a,d   Carvalho, Jose Américo ^a   Fregona, Geisa ^a   Dias, Elias Santos ^a   Cosme, Lorrayne Beliqui ^a   Rodrigues, Rodrigo Ribeiro ^a   Riley, Lee Wood ^b   Maciel, Ethel Leonor Noia ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Programa de Pós graduação em Saúde Coletiva Universidade Federal do Espírito Santo ^*  (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BCG VACCINATION; BRAZIL; CROSS-SECTIONAL STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MALE; OCCUPATIONAL EXPOSURE; PRIMARY HEALTH CARE; TUBERCULIN TEST; COMPARATIVE STUDY; IMMUNOLOGY; LUNG; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY; SECRETION (PROCESS); STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, PULMONARY; VACCINATION;

BCG VACCINE; GAMMA INTERFERON;

ADULT; BCG VACCINE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PRIMARY HEALTH CARE; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84940261761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102773     Document Type: Article

References (46)

1. WHO (2012) "Global tuberculosis report" [periodic na internet]. Available: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502-eng. pdf. Accessed 2013 Jun 11.
2. Cook S, Maw KL, Munsiff SS, Fujiwara PI, Frieden TR (2003) Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001. Infect Control Hosp Epidemiol 24 (11): 807-13.
3. Silva VMC, Cunha AJLA, Kritski AL (2004) Risco de infecção pelo Mycobacterium tuberculosis entre alunos da Faculdade de Medicina da Universidade Federal do Rio de Janeiro. J Bras de Pneumol 30 (5): 459-466.
4. Florence CS, Atherly A, Thorpe KE (2006) Will Choice-Based Reform Work for Medicare? Evidence from the Federal Employees Health Benefits Program. Health Services Research 41(5): 1741-1761.
5. Sociedade Brasileira de Pneumologia e Tisiologia (2004) II Diretrizes Brasileiras para Tuberculose. J Bras de Pneumol 30 (1): 86.
6. Franco C, Zanetta DMT (2004) Tuberculose em profissionais de saúde: medidas institucionais de prevenção e controle. Arq Ci Saúde 11 (4): 244-252.
7. Joshi R, Reingold AL, Menzies D, Pai M (2006) Tuberculosis among Health-Care Workers in Lowand Middle-Income Countries: A Systematic Review. PLoS Med 3 (12): e494.
8. Oliveira SMVL, Honner MR, Paniago AMM, Aguiar ESA, Cunha RV (2007) Prevalência da infecção tuberculosa entre profissionais de um hospital universitário. Rev Latino-Am Enfermagem 15 (6): 1120-1124.
9. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 1; 174(3): 349-55.
10. Maciel ELN, Vieira RCA, Milani EC, Brasil M, Fregona G, et al. (2008) O agente comunitário de saúde no controle da tuberculose: conhecimentos e percepções. Cad Saúde Pública Jun (24): 1377-1386.
11. Moreira TR, Zandonade E, Maciel ELN (2010) Risco de infecção tuberculosa em agentes comunitários de saúde. Rev Saúde Pública 44 (2): 332-338.
12. American Thoracic Society (1990) Diagnostic Standards and classification of tuberculosis. Am Rev Respir Dis 142: 725-735.
13. Reichman LB, Bhavaruju R, editors (2008) Guidelines for the Diagnosis of Latent Tuberculosis Infection in the 21st Century, 2nd Edition. Newark New Jersey Medical School global Tuberculosis Institute.
14. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A (2009) Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot.TB Test in Contact Investigations for Tuberculosis. Chest 135: 1010-1018.
15. Brasil Ministério da Saúde (2011) Manual de recomendações para o controle da tuberculose no Brasil/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. - Brasília: Ministério da Saúde.
16. Brasil Ministério da Saúde-Secretaria Executiva, DATASUS (2012) Available: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2010/d0202.def. Accessed 2014 Feb 4.
17. Altman DG (1991) Practical statistics for medical research. London: Chapman and Hall.
18. Sociedade Brasileira de Pneumologia e Tisiologia (2009) III Diretrizes Brasileiras para Tuberculose. J Bras de Pneumol 35(10): 1018-1048.
19. Menzies D, Joshi R, Pai M (2007) Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11(6): 593-605. Review.
20. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, et al. (2012) Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 67 (1): 62-70.
21. del Corral H, París SC, Marín ND, Marín DM, López L, et al. (2009) IFN gamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 14; 4 (12): e8257.
22. Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, et al. (2011) Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One 4; 6(4): e18206.
23. Roth VR, Garrett DO, Laserson KF, Starling CE, Kritski AL, et al. (2005) A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals. Int J Tuberc Lung Dis 9 (12): 1335-42.
24. Saleiro S, Santos AR, Vidal O, Carvalho T, Torres Costa J, et al. (2007) Tuberculosis in hospital department health care workers. Rev Port Pneumol 13 (6):789-99.
25. Mirtskhulava V, Kempker R, Shields KL, Leonard MK, Tsertsvadze T, et al. (2011) Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis 12(5): 513-9.
26. Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, et al. (2011) Tuberculosis Epidemiological Studies Consortium. Predictors of discordant tuberculin skin test and QuantiFERON-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 15 (8):1056-61.
27. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 8; 293 (22): 2746-55.
28. Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, et al. (2010) Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 23; 10: 220.
29. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, et al. (2006) Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27: 442-448.
30. Zhao X, Mazlagic D, Flynn EA, Hernandez H, Abbott CL (2009) QuantiFERON-TB Blood Assay a Good Replacement for the Tuberculin Skin Test in Tuberculosis Screening? A Pilot Study at Berkshire Medical Center. American. Journal of Clinical Pathology 132(5): 678-686.
31. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011). Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37 (1): 88-99.
32. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, et al. (2009) Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis 13 (4): 446-53.
33. Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, et al. (2008) Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 29 (9): 878-86.
34. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2003) A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 57(9): 804-9. Erratum in: Thorax 58 (2): 188.
35. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, et al. (2005) Discrepancy between the tuberculin skin test and the whole blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis burden country. JAMA 293: 2756-2761.
36. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, et al. (2009) T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13 (1): 84-92.
37. Nienhaus A, Schablon A, Diel R (2008) Interferon-gamma release assay for the diagnosis of latent TB infection-analysis of discordant results, when compared to the tuberculin skin test. PLoS One 16; 3 (7): e2665.
38. Canada (2010) Recommendations on Interferon Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection - 2010 Update. Available: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10pdf/36-acs-5.pdf Accessed 2013 Jul 3.
39. United States of America (2010) Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection - United State. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm. Accessed 2013 Jul 3.
40. Denkinger CM, Dheda K, Pai M (2011) Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17 (6): 806-14.
41. Pai M, Menzies D (2007) The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med 175: 529-531.
42. Trajman A, Steffen RE, Menzies D (2013) Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulmonary Medicine, v. 2013, 1-11.
43. Lee SW, Oh DK, Lee SH, Kang HY, Lee CT, et al. (2011) Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur Respir J 37 (6): 1447-52.
44. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, et al. (2012) Monthly follow-ups of interferon-release assays among health-care workers in contact with patients with TB. Chest v. 142: 1461-1468.
45. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, et al. (2013) Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187: 206-211.
46. Tuuminen T (2013) It is high time to reevaluate QuantiFERON-TB Gold for clinical practice. Clin Vaccine Immunol 20 (11): 1778. Tecnológico